MAJOR TOXIC POLYNEUROPATHIES IN CLINICAL PRACTICE
Keywords:
Metabolic and toxic polyneuropathies, clinical picture, risk factors, therapeutic approaches.Abstract
Polyneuropathies are diseases of the peripheral nervous system with lesions of motor, sensory or autonomic fibers which are encountered by attending physicians of almost all specialties in outpatient and clinical settings. To date, more than 100 different causes of polyneuropathies have been identified. Metabolic and toxic polyneuropathies are the most common in the group of secondary polyneuropathies. Diabetic, alcoholic, uremic, and drug-induced polyneuropathies take the leading place among these diseases. The main forms of diabetic polyneuropathy are presented. The main clinical form is distal symmetrical polyneuropathy. Clinical symptoms depend on the type of fibers involved in the pathological process - thin or thick. There is an assessment scale in points to determine the severity of diabetic polyneuropathy, which helps in clarifying the diagnosis and prognosis of the disease. The next most frequent among metabolic polyneuropathies is uremic polyneuropathy as the most frequent complication in patients suffering from chronic renal insufficiency. Risk factors of uremic polyneuropathy development, clinical picture, the course of the disease are described. Within the framework of toxic polyneuropathies, the main place is given to alcoholic polyneuropathies, chemotherapy-induced, and drug-induced. For each of these categories, clinical forms and pathophysiology of development are described. For all polyneuropathies, the main diagnostic aspects are presented. The main therapeutic approaches are shown. A separate place is given to the use of alpha-lipoic acid.
References
Kieseier B.C., Hartung H.P. Progress in Recognizing and Treating Polyneuropathy. Dtsch Arztebl Int. 2018;115(6):81–82. https://doi.org/ 10.3238/arztebl.2018.0081.
Grantz M., Huan M.C. Unusual peripheral neuropathies. Part I: extrinsic causes. Semin Neurol. 2010;30(4):387–395. https://doi. org/10.1055/s-0030-1267282.
Grantz M. Unusual peripheral neuropathies. Part II: intrinsic reactive causes. Semin Neurol. 2010;30(4):396–404. https://doi. org/10.1055/s-0030-1267283.
Grantz M. Unusual peripheral neuropathies. Part III: intrinsic inherited causes. Semin Neurol. 2010;30(4):405–415. https://doi. org/10.1055/s-0030-1267284.
Burns T.M., Mauermann M.L. The evaluation of polyneuropathies. Neurology. 2011;76(7 Suppl.):6–13. https://doi.org/10.1212/ WNL.0b013e31820c3622.
England J.D., Gronseth G.S., Franklin G., Carter G.T., Kinsella L.J., Cohe J.A. et al. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidencebased review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009;72(2):177–184. https://doi.org/10.1212/01. wnl.0000336345.70511.0f.
Hanewinckel R., van Oijen M., Ikram M.A., van Doorn P.A. The epidemiology and risk factors of chronic polyneuropathy. Eur J Epidemiol. 2016;31(1):5–20. https://doi.org/10.1007/s10654-015-0094-6.
Bharucha N.E., Bharucha A.E., Bharucha E.P. Prevalence of peripheral neuropathy in the Parsi community of Bombay. Neurology. 1991;41(8):1315–1317. https://doi.org/10.1212/wnl.41.8.1315.
Savettieri G., Rocca W.A., Salemi G., Meneghini F., Grigoletto F., Morgante L. et al. Prevalence of diabetic neuropathy with somatic symptoms: a door-to-door survey in two Sicilian municipalities. Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology. 1993;43(6):1115– 1120. https://doi.org/10.1212/wnl.43.6.1115. 10. Cruz M.E., Schoenberg B.S., Ruales J., Barberis P., Proano J., Bossano F. et al. Pilot study to detect neurologic disease in Ecuador among a population with a high prevalence of endemic goiter. Neuroepidemiology. 1985;4(2):108–116. https://doi.org/10.1159/000110221.
Osuntokun B.O., Adeuja A.O., Schoenberg B.S., Bademosi O., Nottidge V.A., Olumide A.O. et al. Neurological disorders in Nigerian Africans: a community-based study. Acta Neurol Scand. 1987;75(1):13–21. https:// doi.org/10.1111/j.1600-0404.1987.tb07883.x.
Cruz Gutierrez-del-Olmo M., Schoenberg B.S., Portera-Sanchez A. Prevalence of neurological diseases in Madrid, Spain. Neuroepidemiology. 1989;8(1):43–47. https://doi.org/10.1159/000110164.
Longe A.C., Osuntokun B.O. Prevalence of neurological disorders in Udo, a rural community in southern Nigeria. Trop Geogr Med. 1989;41(1):36– 40. Available at: https://pubmed.ncbi.nlm.nih.gov/2763344.
Al Rajeh S., Bademosi O., Ismail H., Awada A., Dawodu A., Al-Freihi H. et al. A community survey of neurological disorders in Saudi Arabia: the Thugbah study. Neuroepidemiology. 1993;12(3):164–178. https://doi.org/ 10.1159/000110316.
Kandil M.R., Darwish E.S., Khedr E.M., Sabry M.M., Abdulah M.A. A community-based epidemiological study of peripheral neuropathies in Assiut, Egypt. Neurol Res. 2012;34(10):960–966. https://doi.org/ 10.1179/1743132812Y.0000000099.
Kruja J., Beghi E., Zerbi D., Dobi D., Kuqo A., Zekja I. et al. High prevalence of major neurological disorders in two Albanian communities: results of a door-to-door survey. Neuroepidemiology. 2012;38(3):138–147. https:// doi.org/10.1159/000336348.
